CoChat

Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia

Open access
Gocho, Yoshihiro, Liu, Jingjing, Hu, Jianzhong, Yang, Wentao, Dharia, Neekesh V., Zhang, Jingliao, Shi, Hao, Du, Guoqing, John, August, Lin, Ting-Nien, Hunt, Jeremy, Huang, Xin, Ju, Bensheng, Rowland, Lauren, Shi, Lei, Maxwell, Dylan, Smart, Brandon, Crews, Kristine R., Yang, Wenjian, Hagiwara, Kohei, Zhang, Yingchi, Roberts, Kathryn, Wang, Hong, Jabbour, Elias, Stock, Wendy, Eisfelder, Bartholomew, Paietta, Elisabeth, Newman, Scott, Roti, Giovanni, Litzow, Mark, Easton, John, Zhang, Jinghui, Peng, Junmin, Chi, Hongbo, Pounds, Stanley, Relling, Mary V., Inaba, Hiroto, Zhu, Xiaofan, Kornblau, Steven, Pui, Ching-Hon, Konopleva, Marina, Teachey, David, Mullighan, Charles G., Stegmaier, Kimberly, Evans, William E., Yu, Jiyang, Yang, Jun J. · 2021 · Nature Cancer
Cited by 153

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological malignancy and new therapeutics are much needed. Profiling patient leukemia drug sensitivities ex vivo, we discovered that 44.4% of childhood and 16.7% of adult T-ALL cases exquisitely respond to dasatinib. Applying network-based systems pharmacology analyses to examine signal circuitry, we identified preTCR–LCK activation as the driver of dasatinib sensitivity and T-ALL-specific LCK dependency was confirmed in genome-wide CRISPR-Cas9 screens. Dasatinib-sensitive T-ALL exhibited high BCL-XL activity, low BCL2 activity and venetoclax resistance. Discordant sensitivity of T-ALL to dasatinib and venetoclax is strongly correlated with T-cell differentiation, particularly with the dynamic shift in LCK versus BCL2 activation. Finally, single-cell analysis identified leukemia heterogeneity in LCK and BCL2 signaling and T-cell maturation stage, consistent with dasatinib response. In conclusion, our results indicate that developmental arrest in T-ALL drives differential activation of preTCR–LCK and BCL2 signaling in this leukemia, providing unique opportunities for targeted therapy. Yang and colleagues perform a network system–pharmacology approach and clinical data integration, and identify LCK and BCL2 signaling as the molecular determinants of dasatinib response in pediatric and adult patients with T-ALL.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s43018-020-00167-4

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Cited by

See all 153

Metadata

Authors
Gocho, Y., Liu, J., Hu, J., Yang, W., Dharia, N. V., Zhang, J., Shi, H., Du, G., John, A., Lin, T.-N., Hunt, J., Huang, X., Ju, B., Rowland, L., Shi, L., Maxwell, D., Smart, B., Crews, K. R., Yang, W., Hagiwara, K., Zhang, Y., Roberts, K., Wang, H., Jabbour, E., Stock, W., Eisfelder, B., Paietta, E., Newman, S., Roti, G., Litzow, M., Easton, J., Zhang, J., Peng, J., Chi, H., Pounds, S., Relling, M. V., Inaba, H., Zhu, X., Kornblau, S., Pui, C.-H., Konopleva, M., Teachey, D., Mullighan, C. G., Stegmaier, K., Evans, W. E., Yu, J., & Yang, J. J.
Venue
Nature Cancer
Published
2021-01-21
Volume
2
Issue
3
Pages
284-299
ISSN
2662-1347 (ISSN-L)
OpenAlex
W3122489173
Cited by
153
References
14
FWCI
23.83
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia. https://app.cochat.ai/papers/10.1038/s43018-020-00167-4
The paper
Gocho, Y., Liu, J., Hu, J., Yang, W., Dharia, N. V., Zhang, J., Shi, H., Du, G., John, A., Lin, T.-N., Hunt, J., Huang, X., Ju, B., Rowland, L., Shi, L., Maxwell, D., Smart, B., Crews, K. R., Yang, W., . . . Yang, J. J. (2021). Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia. Nature Cancer. https://doi.org/10.1038/s43018-020-00167-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.